Clariant’s Mevopur medical-grade materials

Clariant’s Mevopur medical-grade materials

February 3, 2020


At MD&M West in Anaheim, California, Clariant marks 10th anniversary of the launch of the Mevopur medical-grade materials portfolio, a highlight of its exhibit in booth #2351.

All Mevopur materials – including color and additive concentrates and ready-to-use polymer compounds – are produced in three dedicated EN:ISO13485-2016 registered facilities and have been pre-tested to support compliance needs of customers in U.S. and Europe. In just the last few years, Clariant has invested heavily to boost compounding capacity at its plant in Lewiston, Maine, and will soon announce expansions in Asia as well. 

New products
At MD&M West, Clariant will feature a new line of polymer compounds specially formulated to resist degradation caused by exposure to high humidity and temperature. The new technology is especially important in applications like catheters that are made of resins that incorporate high loadings of radiopaque metals.

These fillers make devices visible under X-ray fluoroscopy, but they also are known to exacerbate hydrolytic degradation, which can affect critical performance properties and compromise patient safety.

Also on display will be another new range of Mevopur compounds demonstrating Clariant’s capability to modify a given resin family to bring enhanced functionality. Compounds of opaque and transparent ABS have been formulated with antistatic properties, high contrast laser-marking; optically transparent laser-absorbing and -transmitting compounds for laser-welding, and gloss black with improved scratch resistance.